Acromegaly Update podcast

Acromegaly Update — Monday September 28, 2026

0:00
7:00
Rewind 15 seconds
Fast Forward 15 seconds
A quiet week for top-tier acromegaly literature (four papers, mostly real-world/consensus rather than trial data) paired with a livelier rare disease industry week — a first-ever positive pivotal trial in X-linked retinitis pigmentosa and a new FOP approval that goes head-to-head with Regeneron — while Marea's own MAR002 acromegaly program remains the clearest bridge between the two segments following its merger with Lisata.

More episodes from "Acromegaly Update"